Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors

Journal of Controlled Release

Volumn 227, Issue , 2016, Pages 38-44

  Stirland, Darren L ^a   Matsumoto, Yu ^b   Toh, Kazuko ^b   Kataoka, Kazunori ^c   Bae, You Han ^d,e  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF UTAH   (United States)

^e Utah Inha DDS and Advanced Theapeutics Research Center   (South Korea)

Author keywords

Dynamic drug delivery; Extravasation; Nanoparticles; Perfusion; Solid tumors

Indexed keywords

BLOOD VESSELS; FLUORESCENCE; SILICA; TUMORS;

COLOCALIZATION ANALYSIS; DISTANCE ANALYSIS; EXTRAVASATION; FLUORESCENT NANOPARTICLES; PERFUSION; SILICA NANOPARTICLES; SOLID TUMORS; SPATIOTEMPORAL DISTRIBUTIONS;

NANOPARTICLES;

SILICA NANOPARTICLE; DRUG CARRIER; FLUORESCENT DYE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; ELECTRON SPIN RESONANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; NEOPLASMS; NUDE MOUSE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NEOPLASMS; SILICON DIOXIDE;

EID: 84959347974     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.02.016     Document Type: Article

References (30)

1. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan, and A. Chilkoti Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers J. Natl. Cancer Inst. 98 2006 335 344
2. A.J. Primeau, A. Rendon, D. Hedley, L. Lilge, and I.F. Tannock The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors Clin. Cancer Res. 11 2005 8782 8788 10.1158/1078-0432.CCR-05-1664
3. F. Yuan, M. Leunig, S.K. Huang, D.A. Berk, D. Papahadjopoulos, and R.K. Jain Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res. 54 1994 3352 3356
4. D.L. Stirland, J.W. Nichols, E. Jarboe, M. Adelman, M. Dassel, M.-M. Janát-Amsbury, and et al. Uterine perfusion model for analyzing barriers to transport in fibroids J. Control. Release 214 2015 85 93 10.1016/j.jconrel.2015.07.006
5. K.W. Dunn, M.M. Kamocka, and J.H. McDonald A practical guide to evaluating colocalization in biological microscopy AJP Cell Physiol. 300 2011 C723 C742 10.1152/ajpcell.00462.2010
6. E.M.M. Manders, F.J. Verbeek, and J.A. Aten Measurement of co-localization of objects in dual-colour confocal images J. Microsc. 169 1993 375 382 10.1111/j.1365-2818.1993.tb03313.x
7. T. Nomoto, Y. Matsumoto, K. Miyata, M. Oba, S. Fukushima, N. Nishiyama, and et al. In situ quantitative monitoring of polyplexes and polyplex micelles in the blood circulation using intravital real-time confocal laser scanning microscopy J. Control. Release 151 2011 104 109 10.1016/j.jconrel.2011.02.011
8. H. Yamada, C. Urata, Y. Aoyama, S. Osada, Y. Yamauchi, and K. Kuroda Preparation of colloidal mesoporous silica nanoparticles with different diameters and their unique degradation behavior in static aqueous systems Chem. Mater. 24 2012 1462 1471 10.1021/cm3001688
9. J.-H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat. Mater. 8 2009 331 336 10.1038/nmat2398
10. L. Yildirimer, N.T.K. Thanh, M. Loizidou, and A.M. Seifalian Toxicology and clinical potential of nanoparticles Nano Today 6 2011 585 607 10.1016/j.nantod.2011.10.001
11. F. Braet, and E. Wisse Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review Comp. Hepatol. 1 2002 1 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 131011&tool = pmcentrez&rendertype = abstract (accessed October 30, 2013))
12. B.R. Smith, P. Kempen, D. Bouley, A. Xu, Z. Liu, N. Melosh, and et al. Shape matters: Intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation Nano Lett. 12 2012 3369 3377 10.1021/nl204175t (accessed August 16, 2012)
13. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, and et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 6 2011 815 823 10.1038/nnano.2011.166
14. S.D. Perrault, C. Walkey, T. Jennings, H.C. Fischer, and W.C.W. Chan Mediating tumor targeting efficiency of nanoparticles through design Nano Lett. 9 2009 1909 1915 10.1021/nl900031y
15. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664 10.1038/nrclinonc.2010.139
16. H. Hashizume, P. Baluk, S. Morikawa, J.W. McLean, G. Thurston, S. Roberge, and et al. Openings between defective endothelial cells explain tumor vessel leakiness Am. J. Pathol. 156 2000 1363 1380
17. Y. Matsumoto, J. Nichols, K. Toh, T. Nomoto, H. Cabral, Y. Miura, et al., Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery, Nat. Nanotechnol. http://dx.doi.org/10.1038/nnano.2015.342 (in press).
18. T.P. Padera, B.R. Stoll, J.B. Tooredman, D. Capen, E. di Tomaso, and R.K. Jain Pathology: Cancer cells compress intratumour vessels Nat. Commun. 427 2004 695
19. V.P. Chauhan, J.D. Martin, H. Liu, D.A. Lacorre, S.R. Jain, S.V. Kozin, and et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels Nat. Commun. 4 2013 2516 10.1038/ncomms3516
20. P.L. Debbage, J. Griebel, M. Ried, T. Gneiting, A. DeVries, and P. Hutzler Lectin intravital perfusion studies in tumor-bearing mice: Micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor J. Histochem. Cytochem. 46 1998 627 639 10.1177/002215549804600508
21. J. Eckes, O. Schmah, J.W. Siebers, U. Groh, S. Zschiedrich, B. Rautenberg, and et al. Kinetic targeting of pegylated liposomal doxorubicin: A new approach to reduce toxicity during chemotherapy (CARL-trial) BMC Cancer 11 2011 337 (http://www.biomedcentral.com/1471-2407/11/337 (accessed August 10, 2012))
22. C.E. Swenson, L.E. Bolcsak, G. Batist, T.H.J. Guthrie, K.H. Tkaczuk, H. Boxenbaum, and et al. Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer, Anticancer Drugs 14 2003 (http://journals.lww.com/anti-cancerdrugs/Fulltext/2003/03000/Pharmacokinetics-of-doxorubicin-administered-i-v-.8.aspx)
23. G. Batist Cardiac safety of liposomal anthracyclines Cardiovasc. Toxicol. 7 2007 72 74 10.1007/s12012-007-0014-4
24. F. Cavalli, M. Beer, G. Martz, W.F. Jungi, P. Alberto, J.P. Obrecht, and et al. Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: Report of the Swiss Group for Clinical Cancer Research BMJ 286 1983 5 8 10.1136/bmj.286.6358.5
25. P. Francis, J. Crown, A. Di Leo, M. Buyse, A. Balil, M. Andersson, and et al. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial J. Natl. Cancer Inst. 100 2008 121 133 10.1093/jnci/djm287
26. A.S. Fung, L. Wu, and I.F. Tannock Concurrent and sequential administration of chemotherapy and the Mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts Clin. Cancer Res. 15 2009 5389 5395 10.1158/1078-0432.CCR-08-3007
27. M.L. Citron, D.A. Berry, C. Cirrincione, C. Hudis, E.P. Winer, W.J. Gradishar, and et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia J. Clin. Oncol. 21 2003 1431 1439 10.1200/JCO.2003.09.081
28. P. Fournel, G. Robinet, P. Thomas, P.-J. Souquet, H. Léna, A. Vergnenégre, and et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francąis de Pneumo-Cancérologie NPC 95-01 Study J. Clin. Oncol. 23 2005 5910 5917 10.1200/JCO.2005.03.070
29. Y. Bae, T.A. Diezi, A. Zhao, and G.S. Kwon Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents J. Control. Release 122 2007 324 330 10.1016/j.jconrel.2007.05.038
30. D.L. Stirland, J.W. Nichols, S. Miura, and Y.H. Bae Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice J. Control. Release 172 2013 1045 1064